Literature DB >> 27503429

Post chemotherapy retroperitoneal lymph node dissection in germ cell tumor: robotic way.

Girdhar S Bora1, Pankaj Panwar1, Ravimohan S Mavuduru2, Sudheer K Devana1, Shrawan K Singh1, Arup K Mandal1.   

Abstract

Post chemotherapy residual masses are considered extremely challenging to remove even by the most experienced laparoscopic surgeons. Robotic technology has added a new dimension to the management of such cases and has lessened the fear and discomfort associated with such challenging surgery but is still evolving. We present our experience of management of post chemotherapy residual mass with robotic assistance along with tips and tricks required to perform such procedure.

Entities:  

Keywords:  Non-seminomatous germ cell tumors (NSGCT); Post chemotherapy residual mass; Retroperitoneal lymph node dissection (RPLND); Robotic surgery

Mesh：

Substances：

Year:  2016        PMID： 27503429     DOI： 10.1007/s11701-016-0631-7

Source DB:  PubMed          Journal:  J Robot Surg        ISSN： 1863-2483


  15 in total

1.  Robot-assisted laparoscopic retroperitoneal lymph node dissection in an adolescent population.

Authors:  Nicholas G Cost; Daniel G DaJusta; Candace F Granberg; Raven M Cooksey; Carrie E Laborde; Jonathan E Wickiser; Patricio C Gargollo
Journal:  J Endourol       Date:  2012-01-25       Impact factor: 2.942

2.  Robotic-assisted laparoscopic retroperitoneal lymph node dissection.

Authors:  Patrick Davol; Joel Sumfest; Daniel Rukstalis
Journal:  Urology       Date:  2006-01       Impact factor: 2.649

Review 3.  Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy?

Authors:  R S Foster; J P Donohue
Journal:  Urol Clin North Am       Date:  1998-08       Impact factor: 2.241

4.  Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.

Authors:  S D Fosså; S Ous; H H Lien; A E Stenwig
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

5.  Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis.

Authors:  John P Fitzgerald; Barbara Ercole; Dipen J Parekh
Journal:  Indian J Urol       Date:  2010 Jan-Mar

6.  Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.

Authors:  E P Fox; T D Weathers; S D Williams; P J Loehrer; T M Ulbright; J P Donohue; L H Einhorn
Journal:  J Clin Oncol       Date:  1993-07       Impact factor: 44.544

7.  Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

Authors:  Brett S Carver; Bobby Shayegan; Scott Eggener; Jason Stasi; Robert J Motzer; George J Bosl; Joel Sheinfeld
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544

8.  Robot-assisted laparoscopic retroperitoneal lymph node dissection for stage IIIb mixed germ cell testicular cancer after chemotherapy.

Authors:  Sang Hyub Lee; Dong Soo Kim; Sung-Goo Chang; Seung Hyun Jeon
Journal:  Korean J Urol       Date:  2015-07-01

9.  Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.

Authors:  Prem Nath Dogra; Prabhjot Singh; A K Saini; K Subodh Regmi; Bora G Singh; B Nayak
Journal:  Urol Ann       Date:  2013-10

Review 10.  Robotics in urologic oncology.

Authors:  Saurabh Jain; Gagan Gautam
Journal:  J Minim Access Surg       Date:  2015 Jan-Mar       Impact factor: 1.407
View more
  2 in total

1.  Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.

Authors:  Ashwin Sunil Tamhankar; Saurabh Ramesh Patil; Surya Prakash Ojha; Puneet Ahluwalia; Gagan Gautam
Journal:  J Robot Surg       Date:  2019-01-17

2.  Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?

Authors:  C Overs; J B Beauval; L Mourey; P Rischmann; M Soulié; M Roumiguié; Nicolas Doumerc
Journal:  World J Urol       Date:  2018-01-20       Impact factor: 4.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.